Literature DB >> 11094075

Rat protein tyrosine phosphatase eta suppresses the neoplastic phenotype of retrovirally transformed thyroid cells through the stabilization of p27(Kip1).

F Trapasso1, R Iuliano, A Boccia, A Stella, R Visconti, P Bruni, G Baldassarre, M Santoro, G Viglietto, A Fusco.   

Abstract

The r-PTPeta gene encodes a rat receptor-type protein tyrosine phosphatase whose expression is negatively regulated by neoplastic cell transformation. Here we first demonstrate a dramatic reduction in DEP-1/HPTPeta (the human homolog of r-PTPeta) expression in a panel of human thyroid carcinomas. Subsequently, we show that the reexpression of the r-PTPeta gene in highly malignant rat thyroid cells transformed by retroviruses carrying the v-mos and v-ras-Ki oncogenes suppresses their malignant phenotype. Cell cycle analysis demonstrated that r-PTPeta caused G(1) growth arrest and increased the cyclin-dependent kinase inhibitor p27(Kip1) protein level by reducing the proteasome-dependent degradation rate. We propose that the r-PTPeta tumor suppressor activity is mediated by p27(Kip1) protein stabilization, because suppression of p27(Kip1) protein synthesis using p27-specific antisense oligonucleotides blocked the growth-inhibitory effect induced by r-PTPeta. Furthermore, we provide evidence that in v-mos- or v-ras-Ki-transformed thyroid cells, the p27(Kip1) protein level was regulated by the mitogen-activated protein (MAP) kinase pathway and that r-PTPeta regulated p27(Kip1) stability by preventing v-mos- or v-ras-Ki-induced MAP kinase activation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11094075      PMCID: PMC102181          DOI: 10.1128/MCB.20.24.9236-9246.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain.

Authors:  P J Maddon; A G Dalgleish; J S McDougal; P R Clapham; R A Weiss; R Axel
Journal:  Cell       Date:  1986-11-07       Impact factor: 41.582

2.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas.

Authors:  M Loda; B Cukor; S W Tam; P Lavin; M Fiorentino; G F Draetta; J M Jessup; M Pagano
Journal:  Nat Med       Date:  1997-02       Impact factor: 53.440

3.  p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest.

Authors:  K Polyak; J Y Kato; M J Solomon; C J Sherr; J Massague; J M Roberts; A Koff
Journal:  Genes Dev       Date:  1994-01       Impact factor: 11.361

4.  Induction of p27Kip1 degradation and anchorage independence by Ras through the MAP kinase signaling pathway.

Authors:  M Kawada; S Yamagoe; Y Murakami; K Suzuki; S Mizuno; Y Uehara
Journal:  Oncogene       Date:  1997-08-07       Impact factor: 9.867

5.  p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21.

Authors:  H Toyoshima; T Hunter
Journal:  Cell       Date:  1994-07-15       Impact factor: 41.582

6.  Protein tyrosine phosphatase-eta expression is upregulated by the PKA-dependent and is downregulated by the PKC-dependent pathways in thyroid cells.

Authors:  M L Martelli; F Trapasso; P Bruni; M T Berlingieri; C Battaglia; M T Vento; B Belletti; R Iuliano; M Santoro; G Viglietto; A Fusco
Journal:  Exp Cell Res       Date:  1998-11-25       Impact factor: 3.905

7.  LAR-PTPase cDNA transfection suppression of tumor growth of neu oncogene-transformed human breast carcinoma cells.

Authors:  Y Zhai; J Wirth; S Kang; C W Welsch; W J Esselman
Journal:  Mol Carcinog       Date:  1995-10       Impact factor: 4.784

8.  The protein tyrosine phosphatase DEP-1 is induced during differentiation and inhibits growth of breast cancer cells.

Authors:  M M Keane; G A Lowrey; S A Ettenberg; M A Dayton; S Lipkowitz
Journal:  Cancer Res       Date:  1996-09-15       Impact factor: 12.701

9.  Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.

Authors:  A Krishan
Journal:  J Cell Biol       Date:  1975-07       Impact factor: 10.539

10.  The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells.

Authors:  K Okazaki; N Sagata
Journal:  EMBO J       Date:  1995-10-16       Impact factor: 11.598

View more
  37 in total

1.  Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase.

Authors:  Keiko Takahashi; Raymond L Mernaugh; David B Friedman; Rebecca Weller; Nobuo Tsuboi; Hironobu Yamashita; Vito Quaranta; Takamune Takahashi
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-23       Impact factor: 11.205

2.  Crystallization and preliminary X-ray diffraction analysis of rat protein tyrosine phosphatase eta.

Authors:  Huita C Matozo; Alessandro S Nascimento; Maria A M Santos; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2006-08-26

Review 3.  Role of protein tyrosine phosphatases in cancer.

Authors:  Tasneem Motiwala; Samson T Jacob
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

4.  Low-resolution structure and fluorescence anisotropy analysis of protein tyrosine phosphatase eta catalytic domain.

Authors:  Huita C Matozo; Maria A M Santos; Mario de Oliveira Neto; Lucas Bleicher; Luís Mauricio T R Lima; Rodolfo Iuliano; Alfredo Fusco; Igor Polikarpov
Journal:  Biophys J       Date:  2007-03-30       Impact factor: 4.033

5.  Substrate specificity of R3 receptor-like protein-tyrosine phosphatase subfamily toward receptor protein-tyrosine kinases.

Authors:  Juichi Sakuraba; Takafumi Shintani; Sachiko Tani; Masaharu Noda
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

6.  Agonistic anti-CD148 monoclonal antibody attenuates diabetic nephropathy in mice.

Authors:  Keiko Takahashi; Rachel H Kim; Lejla Pasic; Lilly He; Shinya Nagasaka; Daisuke Katagiri; Tracy May; Akira Shimizu; Raymond C Harris; Raymond L Mernaugh; Takamune Takahashi
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

7.  G1 checkpoint failure and increased tumor susceptibility in mice lacking the novel p53 target Ptprv.

Authors:  Gilles Doumont; Alain Martoriati; Chantal Beekman; Sven Bogaerts; Patrick J Mee; Fabrice Bureau; Emanuela Colombo; Myriam Alcalay; Eric Bellefroid; Francesco Marchesi; Eugenio Scanziani; Pier Giuseppe Pelicci; Jean-Christophe Marine
Journal:  EMBO J       Date:  2005-08-18       Impact factor: 11.598

Review 8.  CD45, CD148, and Lyp/Pep: critical phosphatases regulating Src family kinase signaling networks in immune cells.

Authors:  Michelle L Hermiston; Julie Zikherman; Jing W Zhu
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

9.  An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase controlling EGFR endocytosis.

Authors:  Gabi Tarcic; Shlomit K Boguslavsky; Jean Wakim; Tai Kiuchi; Angela Liu; Felicia Reinitz; David Nathanson; Takamune Takahashi; Paul S Mischel; Tony Ng; Yosef Yarden
Journal:  Curr Biol       Date:  2009-11-17       Impact factor: 10.834

10.  Protein tyrosine phosphatases expression during development of mouse superior colliculus.

Authors:  Jacqueline Reinhard; Andrea Horvat-Bröcker; Sebastian Illes; Angelika Zaremba; Piotr Knyazev; Axel Ullrich; Andreas Faissner
Journal:  Exp Brain Res       Date:  2009-09-01       Impact factor: 1.972

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.